{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:54:30Z","timestamp":1791546870676,"version":"4.3.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/Objective:<\/jats:title>\n                    <jats:p>Neoplasms are considered a health problem around the world. This\nstudy systematically examines the effects of Berberine (BBR) and BBR-loaded Nanoparticles (NPs), with\nan emphasis on elucidating the molecular and cellular mechanisms through which these formulations enhance\ncancer immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic literature search (on December 17, 2025) was conducted in PubMed, Scopus, Web\nof Science, and the Cochrane Library electronic databases. Related articles aligned with our study aim were\nscreened, and the required data were extracted and recorded in a table. Moreover, the risk of bias for both\nin vitro and in vivo publications was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Finally, 22 studies were included in the screening process. BBR and its NPs potentially improved\nimmunotherapy outcomes by reducing Programmed Cell Death 1 Receptor (PD-L1) expression (relieving\nPD-1\/PD-L1-mediated immunosuppression), cytokine modulation, immune cell activation and infiltration,\nrepolarization of macrophages from M2 to M1 phenotype, increasing T-cell-mediated cytotoxicity, disrupting\nmitochondrial membrane potential, and promoting the accumulation of intracellular Reactive Oxygen\nSpecies (ROS), inducing pyroptosis and immunogenic cell apoptosis in various cancerous cell lines. BBR\nNPs reduced systemic toxicity, improved sustained drug release, solubility, and drug targeting in tumor\ncells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>BBR and nanoformulated BBR enhance immunotherapy and drug delivery. However, limitations\nof this review were a lack of standardized study design techniques and clinical trial studies. Future\nstudies should focus on cell toxicity, dose-effectiveness, and clinical translation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>BBR and its NPs showed favorable immunomodulatory properties and enhanced cancer immunotherapy\nin experimental studies. However, more clinical studies are needed in this field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715206508700260918112844","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:32:04Z","timestamp":1791545524000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Cancer Immunotherapy with Berberine and Its Loaded Nanoparticles: A Systematic Review"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-9118","authenticated-orcid":true,"given":"Mohadeseh","family":"Karimian","sequence":"first","affiliation":[{"name":"Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-150X","authenticated-orcid":true,"given":"Saber","family":"Abbaszadeh","sequence":"additional","affiliation":[{"name":"Medical Student, Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-2298","authenticated-orcid":true,"given":"Kosar Farhadi","family":"Babadi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health and Safety, Prevention of Cardiovascular Disease Research Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-9394","authenticated-orcid":true,"given":"Alizamen Salehifard","family":"Jouneghani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-3868","authenticated-orcid":true,"given":"Saeid","family":"Heidari-Soureshjani","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0844-3207","authenticated-orcid":true,"given":"Catherine MT","family":"Sherwin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology (Adjunct), Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206508700260918112844","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259038\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206508700260918112844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:32:05Z","timestamp":1791545525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259038\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715206508700260918112844","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}